Company news
Zhejiang Shengda Bio-Pharm Co., Ltd. news in 2025
Zhejiang Shengda Bio-Pharm Co., Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on Changing Signatory Certified Public Accountant
December 29, 2025
Announcement on Lifting of Trading Restrictions for Restricted Shares Issued to Specific Objects
December 18, 2025
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
December 15, 2025
Announcement on Progress in Idle Raised Funds Used for Cash Management
December 12, 2025
Announcement on Resolutions of the 21st Meeting of the 4th Board of Directors
November 27, 2025
Announcement on Completion of Non-trading Transfer under the 2024 Employee Stock Ownership Plan
October 30, 2025
Report for Q3 2025
October 29, 2025
Announcement on Convening the 2025 Q3 Performance Briefing
October 9, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
September 10, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 4, 2025
Announcement on Resolutions of the 17th Meeting of the 4th Board of Supervisors
August 25, 2025
Announcement on Obtaining Government Subsidies
August 19, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
July 23, 2025
Announcement on Expected Increase in Semi-annual Performance for 2025
July 14, 2025
Announcement on Resolutions of the 18th Meeting of the 4th Board of Directors
July 7, 2025
Announcement on Results of Issuing Shares to Specific Objects and Changes in Share Capital
June 27, 2025
Announcement on Opening Special Account for Raised Funds and Signing Agreement on Supervision over Deposit in Special Account for Raised Funds
June 16, 2025
Announcement on Resolutions of the 2024 Annual General Meeting
May 26, 2025
Announcement on Resolution of the 17th Meeting of the 4th Board of Directors
May 22, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
May 19, 2025
Report for Q1 2025
April 27, 2025
Announcement on the Resolution of the 1st Extraordinary General Meeting in 2025
April 23, 2025